Related Experiment Video
Updated: Aug 29, 2025

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
[Hepatic Insulin Resistance and Type 2 Diabetes Mellitus]
Fu-Jun Liu1, Li-Li Chang1, Wei-Lan Wang1
1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering,College of Life Science and Technology, Xinjiang University,Urumqi 830046,China.
Abstract:
Insulin resistance (IR) is a pathological reaction of hyperinsulinemia and impaired glucose tolerance caused by decreased sensitivity of target tissues such as liver to insulin.The pathogenesis of IR as a typical pathological feature of type 2 diabetes is the focus of anti-diabetes research.In this paper,we reviewed the molecular mechanisms of glucose and lipid metabolism,oxidative stress,mitochondrial dysfunction,endoplasmic reticulum stress,inflammation,and hepatic IR in the case of type 2 diabetes mellitus,which might provide new ideas and theoretical guidance for the treatment of diabetes mellitus.
Insights
Insulin resistance (IR), a key feature of type 2 diabetes, involves impaired glucose and lipid metabolism. Understanding its molecular mechanisms, including oxidative stress and inflammation, offers new therapeutic targets for diabetes treatment.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Pathophysiology
Background:
- Insulin resistance (IR) is characterized by hyperinsulinemia and impaired glucose tolerance due to reduced insulin sensitivity in tissues like the liver.
- IR is a central pathological feature of type 2 diabetes mellitus (T2DM).
- Research into anti-diabetes strategies heavily focuses on understanding the pathogenesis of IR.
Purpose of the Study:
- To review the molecular mechanisms underlying insulin resistance in type 2 diabetes.
- To explore the roles of glucose and lipid metabolism, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, and inflammation in hepatic IR.
- To provide theoretical guidance for novel diabetes mellitus treatments.
Main Methods:
- Literature review of molecular mechanisms.
- Analysis of pathways involved in glucose and lipid metabolism.
- Examination of cellular stress responses (oxidative, mitochondrial, ER) and inflammation.
Main Results:
- IR involves complex molecular pathways affecting glucose and lipid homeostasis.
- Oxidative stress, mitochondrial dysfunction, ER stress, and inflammation are critical contributors to hepatic IR in T2DM.
- These interconnected mechanisms highlight the multifaceted nature of insulin resistance.
Conclusions:
- A comprehensive understanding of these molecular mechanisms is crucial for developing effective treatments for T2DM.
- Targeting pathways related to metabolism, stress, and inflammation may offer new therapeutic avenues.
- This review provides insights for future research and clinical strategies in managing diabetes mellitus.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
10:17An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones